3D Cardiac Mapping System Market Size, Share, Industry, Forecast and outlook (2024-2031)

3D Cardiac Mapping System Market Size

The Global 3D Cardiac Mapping System Market reached US$ 471.21 million in 2023 and is expected to reach US$ 977.95 million by 2031, growing at a CAGR of 9.7% during the forecast period 2024-2031.

3D mapping creates a multidimensional image of the heart’s anatomy. During cardiac mapping, the doctor stimulates the heart muscle to watch it beat and identify abnormalities related to a faulty heart rhythm (cardiac arrhythmia). Cardiac mapping is an electrophysiology (EP) procedure, which means it traces the electrical impulses generated by the cells of an individual heart.

3D Cardiac Mapping System Market Scope

For more details on this report – Request for Sample

3D Cardiac Mapping System Market Dynamics

Rise in the prevalence of atrial fibrillation

The increasing prevalence of cardiac arrhythmias, such as atrial fibrillation, ventricular tachycardia, and atrial flutter, is fueling the demand for advanced cardiac mapping systems. These systems aid in the accurate diagnosis and treatment planning for such conditions.

For instance, according to the October 2022 update by the Center for Disease Control and Prevention (CDC), the estimated number of people affected by atrial fibrillation is expected to be 12.1 million by 2030 in the United States. As per the same source, more than 454,000 hospitalisations with AF as the primary diagnosis happen each year in the United States. Thus, the high prevalence of atrial fibrillation across the globe is estimated to be a driving factor for the growth of the market.

High cost associated with the systems

The initial investment required for acquiring 3D cardiac mapping systems is substantial, and the cost of the procedures using these systems can also be significant. This high cost of equipment and procedures can limit adoption, especially in regions with constrained healthcare budgets or in facilities with limited financial resources.

For instance, the current mapping systems capable of creating 3D cardiac maps can cost anywhere from $500,000 to $3 million. The disposable catheters required by these systems, which allow a cardiologist to locate and destroy the heart tissue that's causing the irregular beats, can cost more than $3,000 each.

3D Cardiac Mapping System Market Segment Analysis

The global 3D cardiac mapping system market is segmented based on product type, technology, end-user and region.

The non-contact 3D cardiac mapping systems from the product type  segment accounted for approximately 42.3% of the 3D cardiac mapping system  market share

The non-contact 3D cardiac mapping systems from the product type segment accounted for approximately 42.3%. Most recently, noncontact mapping approaches have had an expanding role in the clinical diagnosis and ablative treatment of complex cardiac arrhythmias. One currently available product, the EnSite  3000 noncontact mapping system (Endocardial Solutions Inc., St. Paul, MN) introduced by Taccardi, is comprised of a catheter-mounted, inflatable multielectrode array, a reference patch electrode, amplifiers, and a Silicon Graphics workstation. To date, this computerized data acquisition system has the capability for 100 analogue inputs, which include 64 inputs from the multielectrode array, a t 2-lead surface ECG, 16 unipolar or bipolar catheter inputs, and 8 user-defined analogue inputs.

For instance, in July 2022, Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced the approval of its AcQMap High-Resolution Imaging and Mapping System and the AcQMap 3D Imaging and Mapping Catheter in Japan.

3D Cardiac Mapping System Market Geographical Analysis

North America is estimated to hold about 41.4% of the total market share throughout the forecast period

North America is estimated to hold about 41.4% of the total market share throughout the forecast period owing to factors like the increasing burden of cardiac diseases, FDA approvals, increase in healthcare expenditures and rise in product launches across North America.

For instance, in January 2022, Abbott received FDA clearance for the EnSITE X EP system with EnSite Omnipolar Technology, a cardiac mapping platform in the United States.

3D Cardiac Mapping System Market Competitive Landscape

The major global players in the market include Abbott, St. Jude Medical, Boston Scientific, Johnson & Johnson Services, Inc, Medtronic Plc, MicroPort Scientific Corporation, Catheter Precision Inc, Koninklijke Philips N.V., Acutus Medical, Siemens Healthineers among others.

Key Developments

• In October 2021, Fortis Memorial Research Institute (Gurgaon) launched a CATH LAB with India’s first ‘3D Electro-Anatomical Mapping Carto 7 machine’. Fortis Memorial Research Institute is the first and only hospital in India and South Asia to acquire an advanced 3D mapping machine.

Why Purchase the Report?

• To visualise the global 3D cardiac mapping system market segmentation based on product type, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of the 3D cardiac mapping system market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global 3D cardiac mapping system market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies